Drug Trial Radar · NCT05010577
Nebulized Bacteriophage Therapy in Cystic Fibrosis Patients With Chronic Pseudomonas Aeruginosa Pulmonary Infection
Last checked: Nov 19, 2026Latest source record: Jul 18, 2025 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
43
Actual
Start
Jun 21, 2022
Primary completion
Mar 10, 2024
Study completion Mar 10, 2024
Sponsor
- Lead sponsor
- BiomX, Inc.Industry
- Sponsor type
- Industry
- First posted
- Aug 18, 2021
Design
- Study type
- Interventional
- Phase
- Phase 1 / Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This is a Phase 1b/2a study with the primary objective to determine if BX004-A is safe and tolerable. Exploratory objectives include whether BX004-A reduces sputum Pseudomonas aeruginosa (PsA) bacterial load in CF subjects with chronic PsA pulmonary infection.
Conditions
- Chronic Pseudomonas Aeruginosa Infection
- Cystic Fibrosis
Interventions
BX004-ADrug
Combination of nebulized bacteriophages targeting Pseudomonas aeruginosa
PlaceboDrug
Nebulized placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Safety and tolerabilityTime frame: 6 months
Locations
28 sites in 5 countries. Site status is shown where the registry gives one.
The University of Alabama at Birmingham
Birmingham, Alabama
Providence Alaska Medical Center
Anchorage, Alaska
University of Arkansas for Medical Sciences
Little Rock, Arkansas
Yale University
New Haven, Connecticut
Children's National Medical Center
Washington D.C., District of Columbia
University of Florida
Gainesville, Florida
Joe DiMaggio Children's Hospital
Hollywood, Florida
Central Florida Pulmonary Group
Orlando, Florida
Boston Children's Hospital
Boston, Massachusetts
New York Medical College
Valhalla, New York
Cincinnati Children's Hospital
Cincinnati, Ohio
University Hospitals Rainbow Babies and Children's Hospital
Cleveland, Ohio
Nationwide Children's Hospital
Columbus, Ohio
Penn State Health Milton S. Hershey Medical Center
Hershey, Pennsylvania
Medical University of South Carolina
Charleston, South Carolina
Baylor College of Medicine, Texas Children Clinic
Houston, Texas
University of Utah
Salt Lake City, Utah
Seattle Children's Hospital
Seattle, Washington
University Hospital in Motol
Prague, Czechia
Rambam Health Care Campus (RHCC) - Ruth Rappaport Children's Hospital
Haifa, Israel
Carmel Medical Center
Haifa, Israel
Hadassah University Medical Center
Jerusalem, Israel
Schneider Children's Medical Center of Israel
Petach Tikvah, Israel
The Chaim Sheba Medical Center
Ramat Gan, Israel
Amsterdam Medical Center
Amsterdam, Netherlands
University Medical Center Utrecht
Utrecht, Netherlands
Vall d'Hebron Barcelona Hospital Campus
Barcelona, Spain
Hospital Clinico Universitario Virgen de la Arrixaca
El Palmar, Murcia, Spain
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.